1. Peptidylarginine deiminases 4 as a promising target in drug discovery
    Chao Yang et al, 2021, European Journal of Medicinal Chemistry CrossRef
  2. PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8
    Xiao-tian Chang et al, 2022, BMC Gastroenterology CrossRef
  3. Défauts d’élimination intracellulaire d’agents infectieux et rhumatismes inflammatoires : la maladie de Whipple comme fil d’Ariane ?
    Jean-Marie Berthelot et al, 2018, Revue du Rhumatisme CrossRef
  4. The PAD4 inhibitor GSK484 enhances the radiosensitivity of triple-negative breast cancer
    Lining Wei et al, 2021, Human & Experimental Toxicology CrossRef
  5. Citrullination in Cancer
    Arseniy E. Yuzhalin, 2019, Cancer Research CrossRef
  6. Impaired intracellular pathogen clearance and inflammatory joint disease: Is Whipple's disease a guiding light?
    Jean-Marie Berthelot et al, 2018, Joint Bone Spine CrossRef
  7. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer
    Lei Zhao et al, 2024, International Journal of Molecular Sciences CrossRef
  8. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A
    Xiaonuan Luo et al, 2022, Neoplasia CrossRef
  9. PADI4 modulates the invasion and migration of osteosarcoma cells by down-regulation of epithelial-mesenchymal transition
    Qiaoli Zhai et al, 2020, Life Sciences CrossRef
  10. GSK484, an inhibitor of peptidyl arginine deiminase 4, increases the radiosensitivity of colorectal cancer and inhibits neutrophil extracellular traps
    Binbin Wang et al, 2023, The Journal of Gene Medicine CrossRef
  11. PAD4 and Its Inhibitors in Cancer Progression and Prognosis
    Di Zhu et al, 2022, Pharmaceutics CrossRef
  12. Lung Cancer Therapy Targeting Histone Methylation: Opportunities and Challenges
    Yuchen Chen et al, 2018, Computational and Structural Biotechnology Journal CrossRef
  13. PADs in cancer: Current and future
    Yu Zhang et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  14. Histone citrullination: a new target for tumors
    Dongwei Zhu et al, 2021, Molecular Cancer CrossRef
  15. Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix
    A. E. Yuzhalin et al, 2018, Nature Communications CrossRef
  16. The Role of Peptidyl Arginine Deiminase IV(PADI4) in Cancers
    Wenjing Wang et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  17. Targeting epigenetic regulators to overcome drug resistance in cancers
    Nan Wang et al, 2023, Signal Transduction and Targeted Therapy CrossRef
  18. DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine
    Guodong Zhang et al, 2022, EPMA Journal CrossRef
  19. MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4
    Chuannan Fan et al, 2019, Oncotarget CrossRef

  20. TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors


    Songlin Song et al, 2020, International Journal of Nanomedicine CrossRef